Group 1 - The core point of the news is that Guoen Co., Ltd. experienced a stock price increase of 5.07%, reaching 59.47 CNY per share, with a trading volume of 280 million CNY and a turnover rate of 2.74%, resulting in a total market capitalization of 16.131 billion CNY [1] - Guoen Co., Ltd. is located in Qingdao, Shandong Province, and was established on December 22, 2000. The company was listed on June 30, 2015, and its main business involves the research, production, and sales of modified plastic particles and various modified plastic products [1] - The revenue composition of Guoen Co., Ltd. includes: organic polymer modified materials (50.38%), green petrochemical materials and new materials (20.11%), organic polymer composite materials (17.71%), others (8.02%), biomedicine and health products (2.05%), and gelatin, collagen, and their derivatives (1.73%) [1] Group 2 - According to data, one fund under China Europe Fund holds a significant position in Guoen Co., Ltd. The China Europe Chemical Industry Mixed Fund A (024640) held 323,000 shares in the third quarter, accounting for 6.24% of the fund's net value, making it the third-largest holding [2] - The China Europe Chemical Industry Mixed Fund A (024640) was established on August 13, 2025, with a latest scale of 43.6124 million CNY. The fund has achieved a return of 4.28% this year, ranking 3287 out of 9012 in its category, and a cumulative return of 28.62% since inception [2]

Group 1 - The core point of the news is that Guoen Co., Ltd. experienced a stock price increase of 5.07%, reaching 59.47 CNY per share, with a total market capitalization of 16.131 billion CNY [1] - Guoen Co., Ltd. is primarily engaged in the research, production, and sales of modified plastic particles and various modified plastic products, with its main business revenue composition being: organic polymer modified materials 50.38%, green petrochemical materials and new materials 20.11%, organic polymer composite materials 17.71%, others 8.02%, biomedicine and health products 2.05%, and gelatin, collagen, and their derivatives 1.73% [1] - The company is located in Qingdao, Shandong Province, and was established on December 22, 2000, with its listing date on June 30, 2015 [1] Group 2 - From the perspective of fund holdings, one fund under Huatai PineBridge holds Guoen Co., Ltd. as a significant investment, with the Huatai Zhongzheng 2000 ETF (159536) holding 3,400 shares, accounting for 0.31% of the fund's net value [2] - The Huatai Zhongzheng 2000 ETF (159536) has a total scale of 53.8093 million CNY and has achieved a return of 5.32% this year, ranking 2122 out of 5580 in its category [2] - The fund has a one-year return of 49.92%, ranking 1314 out of 4203 in its category, and a cumulative return since inception of 49.58% [2]

格隆汇1月9日丨国恩股份(002768.SZ)公布，根据本次发行并上市的时间安排及香港联交所的相关要 求，公司已于2026年1月9日向香港联交所更新递交了本次发行并上市的申请，并于同日在香港联交所网 站刊登了本次发行并上市的更新申请资料。该相关申请资料为公司按照香港证券及期货事务监察委员会 （简称"香港证监会"）及香港联交所的要求编制和刊发，为草拟版本，其所载资料可能会适时作出更新 和修订。 ...

青岛国恩科技股份有限公司 章程（草案） （H 股发行并上市后适用） 二〇二六年一月 | | | 青岛国恩科技股份有限公司 章程（草案） 第一章 总则 第一条 为维护公司、股东、职工和债权人的合法权益，规范公司的组织和 行为，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《境内企业境外发行证券和上 市管理试行办法》、《香港联合交易所有限公司证券上市规则》（以下简称"《香 港上市规则》"）和其他有关规定，制定本章程。 第二条 公司系依照《公司法》《证券法》和其他有关规定成立的股份有限 公司（以下简称"公司"）。 公司由原青岛国恩科技发展有限公司全体股东共同作为发起人，以原青岛国 恩科技发展有限公司账面净资产整体折股进行整体变更的方式设立，在青岛市市 场 监 督 管 理 局 注 册 登 记 ， 取 得 营 业 执 照 ， 统 一 社 会 信 用 代 码 为 913702007255650680。 第三条 公司于 2015 年 6 月 9 日经中国证券监督管理委员会（以下简称"中 国证监会"）批准，首次向社会公众发行人民币普通股 2,000 万股，于 2 ...

鉴于本次发行并上市的认购对象仅限于符合相关条件的境外投资者及依据 中国相关法律法规有权进行境外证券投资的境内合格投资者，公司将不会在境 内证券交易所的网站和符合境内监管机构规定条件的媒体上刊登该申请资料， 但为使境内投资者及时了解该等申请资料披露的本次发行并上市以及公司的其 他相关信息，现提供该申请资料在香港联交所网站的查询链接供查阅： 中文： 股票代码：002768 股票简称：国恩股份 公告编号：2026-001 青岛国恩科技股份有限公司 关于申请发行境外上市外资股（H 股）并上市的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 青岛国恩科技股份有限公司（以下简称"公司"）正在进行申请发行境外 上市外资股（H 股）并在香港联合交易所有限公司（以下简称"香港联交所"） 主板挂牌上市（以下简称"本次发行并上市"）的相关工作。公司已于 2025 年 6 月 26 日向香港联交所递交了本次发行并上市的申请，并于同日首次在香港联 交所网站刊登了申请资料。 根据本次发行并上市的时间安排及香港联交所的相关要求，公司已于 2026 年 1 月 9 日向香港联交所更 ...

青岛国恩科技股份有限公司 关于修订 H 股发行并上市后适用的《公司章程（草案）》 的公告 2025 年 6 月 6 日，青岛国恩科技股份有限公司（以下简称"公司"）召开 2024 年度股东大会，审议通过了《关于就公司发行 H 股股票并上市修订<公司章 程>及其附件议事规则的议案》。本次股东会授权董事会及其授权人士，为本次 发行并上市之目的，根据境内外法律、法规及规范性文件的规定或者境内外有关 政府部门和监管机构的要求与建议以及本次发行并上市的实际情况等，对《公司 章程（草案）》进行调整和修改，包括但不限于对文字、章节、条款、生效条件、 生效时间、注册资本、股权结构等进行调整和修改，向公司登记机构及其他相关 政府部门办理变更登记、审批或备案等事宜（如涉及）。 根据上述股东会的授权，为公司本次发行并上市之目的，2026 年 1 月 9 日， 公司召开第五届董事会第十六次会议，审议通过了《关于修订<公司章程（草案）> 的议案》，董事会同意根据香港交易及结算所有限公司的修改意见修订本次发行 并上市后适用的《公司章程（草案）》。具体修订内容如下： 股票代码：002768 股票简称：国恩股份 公告编号：2026-003 ...

股票代码：002768 股票简称：国恩股份 公告编号：2026-002 青岛国恩科技股份有限公司 第五届董事会第十六次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 青岛国恩科技股份有限公司（以下简称"公司"或"国恩股份"）第五届董 事会第十六次会议于 2026 年 1 月 9 日下午 14:00 在青岛市城阳区棘洪滩街道青 大工业园 2 号路公司办公楼四楼会议室召开。本次会议由公司董事长王爱国先生 召集并主持，会议通知于 2026 年 1 月 6 日以专人送达、电子邮件、电话等形式 发出。本次会议采取现场及通讯表决的方式召开，应参加本次会议表决的董事 7 人，实际参加本次会议表决的董事为 7 人，公司高级管理人员列席了本次会议。 本次会议的召集、召开和表决程序符合《中华人民共和国公司法》（以下简称《公 司法》）和《青岛国恩科技股份有限公司章程》（以下简称《公司章程》）的有 关规定，合法有效。 二、董事会会议审议情况 三、备查文件 1、青岛国恩科技股份有限公司第五届董事会第十六次会议决议。 特此公告。 1、审议通过《关于确 ...

Company Overview - Guoen Technology is a Chinese supplier focused on new chemical materials and gelatin, collagen upstream and downstream products, serving the chemical and health industries [4] - The company engages in research, production, and sales of products for industrial and commercial use, with clients including manufacturers in automotive, new energy, and home appliances [4] - In the health sector, Guoen Technology's clients include medical and pharmaceutical manufacturers who use its products as raw materials for supplements and medications [4] Market Position - According to Frost & Sullivan, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, with a market share of 2.5% in 2024 [5] - The company is the largest polystyrene producer in China by production capacity in 2024 [5] - In the health sector, Guoen Technology is the second-largest bone gelatin producer in China by output and the largest domestic brand in the same category [5] Financial Performance - The company reported revenues of approximately RMB 134.06 billion, RMB 174.39 billion, RMB 191.88 billion, and RMB 174.44 billion for the fiscal years 2022, 2023, 2024, and the first ten months of 2025, respectively [6] - The net profit for the same periods was RMB 7.24 billion, RMB 5.4 billion, RMB 7.21 billion, and RMB 7.21 billion [7] - The return on equity for the fiscal years 2022, 2023, 2024, and the first ten months of 2025 was 12.3%, 8.5%, 10.2%, and 9.5%, respectively [10] Industry Overview - The global polymer materials market is projected to grow from RMB 298.9 billion in 2020 to RMB 456.15 billion in 2024, with a compound annual growth rate (CAGR) of 11.1% [12] - China's polymer materials market is expected to expand from RMB 110.8 billion in 2020 to RMB 162.8 billion in 2024, with a CAGR of 10.1% [12] - The organic polymer modified materials and organic polymer composite materials market is anticipated to grow from RMB 84.81 billion in 2020 to RMB 150.38 billion in 2024, with a CAGR of 15.4% [14]

Company Overview - Guoen Technology is a Chinese supplier focused on new chemical materials and upstream and downstream products of gelatin and collagen, serving the chemical and health industries [4] - The company has a diverse customer base, including manufacturers in the automotive, new energy, and home appliance sectors, as well as medical and pharmaceutical manufacturers in the health sector [4] Market Position - According to Frost & Sullivan, Guoen Technology is the second-largest company in China for organic polymer modified materials and organic polymer composite materials by sales revenue, with a market share of 2.5% in 2024 [5] - The company is also the largest producer of polystyrene in China by production capacity in 2024 [5] - In the health sector, Guoen Technology's subsidiary Dongbao Bio has established a comprehensive product layout from collagen peptides to end products, becoming a significant player in the health industry [5] Financial Performance - The company reported revenues of approximately RMB 134.06 billion, RMB 174.39 billion, RMB 191.88 billion, and RMB 174.44 billion for the fiscal years 2022, 2023, 2024, and the first ten months of 2025, respectively [6] - The net profit for the same periods was RMB 7.24 billion, RMB 5.4 billion, RMB 7.21 billion, and RMB 7.21 billion [7] - The return on equity for the fiscal years 2022, 2023, 2024, and the first ten months of 2025 was 12.3%, 8.5%, 10.2%, and 9.5%, respectively [9] Industry Overview - The global polymer materials market is expected to grow from RMB 298.9 billion in 2020 to RMB 456.15 billion in 2024, with a compound annual growth rate (CAGR) of 11.1% from 2020 to 2024 [11] - China's polymer materials market is projected to expand from RMB 110.8 billion in 2020 to RMB 162.8 billion in 2024, with a CAGR of 10.1% [11] - The market for organic polymer modified materials and organic polymer composite materials in China is expected to grow from RMB 303.8 billion in 2020 to RMB 544.8 billion in 2024, with a CAGR of 15.7% [14]

Group 1 - The core point of the article is that Qingdao Gon Technology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with China Merchants Securities International as the sole sponsor [1]. - The company previously submitted a listing application on June 26, 2025 [1]. - Qingdao Gon Technology specializes in new chemical materials and upstream and downstream products of gelatin and collagen, serving the chemical and health industries [1]. Group 2 - The company is engaged in the research, development, production, and sales of products for industrial and commercial use [1].